🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2012-06-01
Trial ID
NCT01506271
Treatments Being Tested
The purpose of the ACTHEON Study is to evaluate the in vitro activity of ce...
Status
Unknown
Location
HG Gregorio Marañón
Start Date
2019-11-01
Trial ID
NCT04196608
Treatments Being Tested
There is established evidence that patients with Cystic Fibrosis (CF) may h...
Status
Terminated
Location
Children's Hospital Los Angeles
Start Date
2023-01-03
Trial ID
NCT05561764
Treatments Being Tested
This study will evaluate the efficacy and safety of a FDC of imipenem/cilas...
Status
Completed
Location
Santa Casa de Misericordia de Belo Horizonte ( Site 0300)
Start Date
2018-09-18
Trial ID
NCT03583333
Treatments Being Tested
Critically ill patients with sepsis undergo several physiological alteratio...
Status
Completed
Location
Hartford Hospital
Start Date
2020-02-10
Trial ID
NCT04147221
Treatments Being Tested
This study aims to compare treatment with Imipenem/Cilastatin-XNW4107 (IMI-...
Status
Completed
Location
Denver Health and Hospital Authority
Start Date
2022-07-31
Trial ID
NCT05204563
Treatments Being Tested
The study will evaluate the efficacy and safety of imipenem+cilastatin/rele...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-21
Trial ID
NCT02452047
Treatments Being Tested
This study aims to compare treatment with a fixed-dose combination (FDC) of...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-24
Trial ID
NCT02493764
Treatments Being Tested
Antibiotic resistance is a growing global health problem of great concern, ...
Status
Completed
Location
Sahlgrenska University Hospital
Start Date
2021-11-01
Trial ID
NCT05048693
The study will evaluate the efficacy and safety of imipenem+cilastatin/rele...
Status
Completed
Location
Nagoya Ekisaikai Hospital ( Site 1724)
Start Date
2017-10-04
Trial ID
NCT03293485
Treatments Being Tested